552 participants
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-01
- Start Date:
- 2019-09-17
- Completion:
- 2025-11-04
Conditions
- Chronic Lymphocytic Leukemia
Interventions
- DRUG